Stock Market News for May 29, 2026

U.S. equities closed higher, with the S&P 500 up 0.6% to 7,563.63 and the Nasdaq up 0.9% to 26,917.47, both at record highs, as AI optimism and defensive healthcare buying outweighed inflation concerns. The VIX fell 3.4% to 15.74, while geopolitics eased after reports of a potential 60-day U.S.-Iran ceasefire extension. Key data were mixed: initial jobless claims rose to 215,000, PCE inflation increased 0.4% in April, and Q1 GDP was revised down to 1.6%.

Analysis

The tape is telling us the market is rewarding inflation insulation and duration-sensitive growth at the same time, which is unusual and usually only persists when positioning is still underweight both. Healthcare’s outperformance is not just defensive rotation; it signals investors are paying up for stable pricing power and reimbursement visibility while ignoring cyclicals with margin compression risk. That makes the current move more about factor re-rating than pure macro relief, and it tends to favor large-cap quality over lower-margin defensives.

The real second-order effect is that geopolitics is being translated into a capex theme, not an oil shock theme. If markets continue to price elevated Middle East risk without a sustained energy spike, the beneficiaries shift toward cybersecurity, satellite comms, defense electronics, and grid/infrastructure names rather than upstream energy. That is bullish for firms with AI-enabled enterprise spend exposure and resilient backlog, but it also raises the bar for names that need a clean macro cycle to compound.

The inflation data keeps the Fed path sticky, which matters because the market is currently buying earnings resilience in spite of real-rate pressure. That usually works for a few weeks, but if rates reprice higher again, the most fragile part of the rally is long-duration tech without near-term cash-flow credibility. Healthcare can keep working, but the higher-quality earnings growers should outperform the broad software cohort if discount rates stay elevated.

Consensus is probably underestimating how much of this rally is a positioning squeeze rather than a fundamental regime shift. With volatility already compressed, upside in equities may continue in a shallow grind, but single-stock dispersion should increase sharply around macro prints and any ceasefire headlines. In that environment, owning idiosyncratic winners while fading low-quality beta is better than chasing index exposure.

Key Decisions for Investors

• Overweight LLY versus the broad market for the next 1-3 months: quality healthcare remains the cleanest hedge against sticky inflation, with lower earnings volatility and better pricing power than most defensives. Risk/reward: modest upside, low drawdown; trim if real yields re-accelerate.
• Buy MRVL on pullbacks and express it as a relative long versus semis with weaker AI monetization visibility over the next 4-8 weeks. The setup favors names that can translate AI demand into revenue now, not just narrative exposure; stop if guidance risk broadens across the AI capex stack.
• Initiate a pair trade: long XLV / short XLY for the next 1-2 months. If inflation stays sticky and growth slows, consumer discretionary should face margin and demand pressure while healthcare maintains defensive bid; unwind if consumer confidence data re-accelerates.
• Consider a small long basket in cybersecurity/defense-infrastructure beneficiaries as a geopolitical hedge over the next 1-3 months. Use any ceasefire-related headline risk to buy weakness; the asymmetric upside is from sustained enterprise and sovereign spending, not from immediate conflict escalation.
• Fade low-vol index chasing via short-dated SPY call spreads only if VIX stays below the mid-teens into the next macro print. With realized volatility still subdued, upside is capped unless rates or geopolitics improve materially; keep size small because momentum can extend longer than fundamentals justify.